The methods for removal of direct oral anticoagulants and heparins to improve the monitoring of hemostasis: a narrative literature review
The assessment of hemostasis is necessary to make suitable decisions on the management
of patients with thrombotic disorders. In some clinical situations, for example, during …
of patients with thrombotic disorders. In some clinical situations, for example, during …
An update on applications and limitations of direct oral anticoagulants
S Wei, A Sawhney, H Khandait, A Meda… - The Egyptian Journal of …, 2023 - Springer
A major advancement in the field of medicine has been the introduction and usage of direct
oral anticoagulants (DOACs) such as dabigatran (Pradaxa), apixaban (Eliquis), and …
oral anticoagulants (DOACs) such as dabigatran (Pradaxa), apixaban (Eliquis), and …
Direct oral anticoagulants for deep vein thrombosis among patients with hereditary thrombophilia—A cohort study
G Galyfos, A Chamzin, G Charalampopoulos… - …, 2023 - journals.sagepub.com
Objectives to evaluate direct oral anticoagulants (DOACs) in patients with hereditary
thrombophilia and deep venous thrombosis (DVT). Methods This is a retrospective …
thrombophilia and deep venous thrombosis (DVT). Methods This is a retrospective …
The Black Death ravaging Europe in the fourteenth century might be the pathogen-driven selective pressure for factor V Leiden
FS Fan - Medical Hypotheses, 2023 - Elsevier
Factor V Leiden as a mutant gene defect of hereditary thrombophilia exists peculiarly in
Caucasians but almost absent in people traditionally living in Asia. This lopsided …
Caucasians but almost absent in people traditionally living in Asia. This lopsided …
A novel mutation p. Met1Val in SERPINC1 gene causes hereditary antithrombin deficiency in a Chinese family with thrombotic disease
M Zeng, K Jia, M Liu, M Wang… - Thrombosis …, 2023 - pubmed.ncbi.nlm.nih.gov
A novel mutation p.Met1Val in SERPINC1 gene causes hereditary antithrombin deficiency
in a Chinese family with thrombotic disease A novel mutation p.Met1Val in SERPINC1 gene …
in a Chinese family with thrombotic disease A novel mutation p.Met1Val in SERPINC1 gene …
Deficiency of Natural Anticoagulants Involves in the Occurrence of Arterial Thrombosis
TTM Nguyen, MP Vu, TT Nguyen, HY Duong - Plasmatology, 2023 - journals.sagepub.com
Background The role of natural anticoagulant deficiency in the development of arterial
thrombosis (AT) is controversial. Objective Our objectives were to assess the deficiency of …
thrombosis (AT) is controversial. Objective Our objectives were to assess the deficiency of …
[HTML][HTML] The Combined Heterozygosity of Factor V Leiden and G20210A Prothrombin Gene Mutation in a Patient With Venous Thromboembolism
M Machado, M Cunha, F Gonçalves, C Fernandes… - Cureus, 2023 - ncbi.nlm.nih.gov
Venous thromboembolism (VTE) is a chronic illness that includes pulmonary embolism (PE)
and deep vein thrombosis (DVT), and many risk factors are associated. Anticoagulation …
and deep vein thrombosis (DVT), and many risk factors are associated. Anticoagulation …
Déficit Combinado de Proteína C y S de la Coagulación en Paciente Joven como Causa de Enfermedad Cerebrovascular Isquémica, a Propósito de 1 caso Clínico
LAD Sarmiento, CAP Rincón… - Ciencia Latina …, 2023 - ciencialatina.org
La proteína C (PC) es un precursor de la serina proteasa, proteína C activada (PCA). Su
activación proteolítica por trombina ocurre en la superficie del endotelio células e involucra …
activación proteolítica por trombina ocurre en la superficie del endotelio células e involucra …
[PDF][PDF] НАСЛЕДСТВЕННЫЕ ТРОМБОФИЛИИ ЛЕКЦИЯ
ЛП Папаян, ОГ Головина, ОЮ Матвиенко… - ВЕСТНИК …, 2023 - bloodscience.ru
Развитие эпизодов венозного тромбоэмболизма представляет значительную
проблему в различных областях медицины и установление факторов риска развития …
проблему в различных областях медицины и установление факторов риска развития …